| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1515/JPM.2011.077 |
| P698 | PubMed publication ID | 21848482 |
| P50 | author | Alexandra Matias | Q37837434 |
| P2093 | author name string | Ana Catarina Pedrosa | |
| P2860 | cites work | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration | Q27860581 |
| The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia. | Q31132787 | ||
| An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. | Q33221698 | ||
| Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis | Q33323271 | ||
| Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry | Q33329370 | ||
| Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia | Q33371864 | ||
| Subclassification of preeclampsia | Q35196220 | ||
| World Health Organization systematic review of screening tests for preeclampsia | Q35968177 | ||
| The cost of preterm birth: the low cost versus high value of tocolysis | Q36700819 | ||
| Placental origins of preeclampsia: challenging the current hypothesis | Q37079631 | ||
| Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review | Q37665733 | ||
| Assessment of risk for the development of pre-eclampsia by maternal characteristics and uterine artery Doppler | Q43529000 | ||
| Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy | Q46608541 | ||
| Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation | Q46956814 | ||
| Maternal plasma inhibin A at 11-13 weeks of gestation in hypertensive disorders of pregnancy | Q47889999 | ||
| First-trimester prediction of hypertensive disorders in pregnancy. | Q51775989 | ||
| Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. | Q51822307 | ||
| Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler. | Q54003950 | ||
| Pre-eclampsia | Q56019568 | ||
| Prospective evaluation of the risk of pre-eclampsia using logistic regression analysis | Q56994690 | ||
| Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction | Q57316953 | ||
| P433 | issue | 6 | |
| P921 | main subject | pre-eclampsia | Q61335 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 619-635 | |
| P577 | publication date | 2011-08-17 | |
| P1433 | published in | Journal of Perinatal Medicine | Q15753400 |
| P1476 | title | Screening for pre-eclampsia: a systematic review of tests combining uterine artery Doppler with other markers | |
| P478 | volume | 39 |
| Q87406032 | A novel three-step approach for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation |
| Q90737682 | Diagnostic Performance of First Trimester Screening of Preeclampsia Based on Uterine Artery Pulsatility Index and Maternal Risk Factors in Routine Clinical Use |
| Q36125098 | Early detection of maternal risk for preeclampsia |
| Q92980466 | Evaluation of Serum Biomarkers and Other Diagnostic Modalities for Early Diagnosis of Preeclampsia |
| Q33863973 | Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia |
| Q34619975 | Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia. |
| Q38227251 | Pre-eclampsia part 2: prediction, prevention and management |
| Q46322861 | Prediction of preeclampsia by combining serum histidine-rich glycoprotein and uterine artery Doppler |
| Q38207099 | Predictive biomarkers of pre-eclampsia and effectiveness of preventative interventions for the disease |
| Q50638104 | Screening for pre-eclampsia early in pregnancy: performance of a multivariable model combining clinical characteristics and biochemical markers. |
| Q41574187 | Uterine artery pulsatility index in the three trimesters of pregnancy: effects of maternal characteristics and medical history |
Search more.